Bank Julius Baer & Co
UTHR icon

Bank Julius Baer & Co’s United Therapeutics UTHR Stock Holding History

Bank Julius Baer & Co’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28M Buy
6,050
+581
+11% +$327K 0.01% 285
2026
Q1 		$3.22M Sell
5,469
-241
-4% -$120K 0.01% 273
2025
Q4 		$2.83M Sell
5,710
-542
-9% -$252K 0.01% 280
2025
Q3 		$2.62M Buy
+6,252
New +$2.1M 0.01% 302
2021
Q1 		– Sell
-283
Closed -$43K – 902
2020
Q4 		$43K Buy
+283
New +$37.1K ﹤0.01% 703

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bank Julius Baer & Co's UTHR Position: Q2 2026 in Review

Bank Julius Baer & Co increased its United Therapeutics (UTHR) stake by 11% in Q2 2026, buying an estimated $327K and bringing the position to 6,050 shares worth $3.28M. The position accounts for 0.01% of the portfolio, ranked #285.

Bank Julius Baer & Co first reported a position in UTHR in Q4 2020 and has held it in 5 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bank Julius Baer & Co held 6,050 shares of United Therapeutics worth $3.28M as of Q2 2026.
  • Bank Julius Baer & Co bought 581 United Therapeutics shares in Q2 2026, an estimated $327K.
  • United Therapeutics made up 0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #285 holding.
  • Bank Julius Baer & Co first reported a position in United Therapeutics in Q4 2020 and has held it in 5 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.